# A Study of Lifileucel (Tumor-infiltrating Lymphocytes) in Adults With Advanced Soft Tissue Sarcoma

> **NCT07741877** · PHASE2 · RECRUITING · sponsor: **Iovance Biotherapeutics, Inc.** · enrollment: 80 (estimated)

## Conditions studied

- Sarcoma
- Soft Tissue Sarcoma (STS)
- Advanced Soft Tissue Sarcoma
- Undifferentiated Pleomorphic Sarcoma (UPS)
- Dedifferentiated Liposarcoma (DDLPS)

## Interventions

- **BIOLOGICAL:** Lifileucel

## Key facts

- **NCT ID:** NCT07741877
- **Lead sponsor:** Iovance Biotherapeutics, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2026-10-02
- **Primary completion:** 2033-09-01
- **Final completion:** 2034-09-01
- **Target enrollment:** 80 (ESTIMATED)
- **Last updated:** 2026-10-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07741877

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07741877, "A Study of Lifileucel (Tumor-infiltrating Lymphocytes) in Adults With Advanced Soft Tissue Sarcoma". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07741877. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*